Tacrolimus Dose Requirements in African-American and Caucasian Kidney Transplant Recipients On Mycophenolate and Prednisone.

被引：0
|
作者：
Beermann, K. [1 ]
Ellis, M. [1 ]
Sudan, D. [1 ]
Harris, M. [1 ]
机构：
[1] Duke Hosp, Durham, NC USA
来源：
TRANSPLANTATION | 2014年 / 98卷
关键词：
D O I：
10.1097/00007890-201407151-02827
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
B1200
引用
收藏
页码：827 / 828
页数：2
相关论文
共 50 条
  • [1] Tacrolimus Dose Requirements in African-American and Caucasian Kidney Transplant Recipients On Mycophenolate and Prednisone.
    Beermann, K.
    Ellis, M.
    Sudan, D.
    Harris, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 827 - 828
  • [2] Tacrolimus dose requirements in African-American and Caucasian kidney transplant recipients on mycophenolate and prednisone
    Beermann, Kristi J.
    Ellis, Matthew J.
    Sudan, Debra L.
    Harris, Matthew T.
    CLINICAL TRANSPLANTATION, 2014, 28 (07) : 762 - 767
  • [3] Comparison of tacrolimus dose requirements between African and caucasian renal transplant recipients
    Rosa, P
    Alejandra, S
    Cecilia, M
    THERAPEUTIC DRUG MONITORING, 2003, 25 (04) : 502 - 502
  • [4] Single center analysis of mycophenolate mofetil and neoral/prednisone therapy for prophylaxis of rejection in African-American and Caucasian transplant recipients
    Weber, M
    Ketchum, RJ
    Sellers, M
    Aradhye, S
    Deng, S
    Grossman, R
    Shaw, L
    Naji, A
    Barker, C
    Brayman, KL
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) : 338 - 339
  • [5] Effect of Everolimus With Low Dose Tacrolimus Vs Mycophenolate With Standard Tacrolimus Regimen in African-American De Novo Renal Transplant Recipients
    Peddi, V.
    Qazi, Y.
    Shaffer, D.
    Luan, F.
    Shihab, F.
    Tomlanovich, S.
    McCague, K.
    Patel, D.
    Mulgaonkar, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 536 - 536
  • [6] Genotype-guided tacrolimus dosing in African-American kidney transplant recipients
    Sanghavi, K.
    Brundage, R. C.
    Miller, M. B.
    Schladt, D. P.
    Israni, A. K.
    Guan, W.
    Oetting, W. S.
    Mannon, R. B.
    Remmel, R. P.
    Matas, A. J.
    Jacobson, P. A.
    PHARMACOGENOMICS JOURNAL, 2017, 17 (01): : 61 - 68
  • [7] Genotype-guided tacrolimus dosing in African-American kidney transplant recipients
    K Sanghavi
    R C Brundage
    M B Miller
    D P Schladt
    A K Israni
    W Guan
    W S Oetting
    R B Mannon
    R P Remmel
    A J Matas
    P A Jacobson
    The Pharmacogenomics Journal, 2017, 17 : 61 - 68
  • [8] The use of daclizumab, tacrolimus and mycophenolate mofetil in African-American and Hispanic first renal transplant recipients
    Ciancio, G
    Burke, GW
    Suzart, K
    Mattiazzi, A
    Vaidya, A
    Roth, D
    Kupin, W
    Rosen, A
    Johnson, N
    Miller, J
    AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (08) : 1010 - 1016
  • [9] Effect of Everolimus With Low Dose Tacrolimus Vs Mycophenolate With Standard Tacrolimus Regimen in African-American De Novo Renal Transplant Recipients.
    Peddi, V.
    Qazi, Y.
    Shaffer, D.
    Luan, F.
    Shihab, F.
    Tomlanovich, S.
    McCague, K.
    Patel, D.
    Mulgaonkar, S.
    TRANSPLANTATION, 2014, 98 : 536 - 536
  • [10] Outcomes of African-American kidney-transplant recipients treated with sirolimus, tacrolimus, and corticosteroids
    Egidi, MF
    Gaber, AO
    TRANSPLANTATION, 2003, 75 (04) : 572 - 572
12345